Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / *W EXP 02/10/202
-
Total 13F shares
-
3,472,082
-
Share change
-
-226,848
-
Total reported value
-
$798,578
-
Price per share
-
$0.23
-
Number of holders
-
20
-
Value change
-
-$14,910
-
Number of buys
-
3
-
Number of sells
-
6
Institutional Holders of NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) as of Q4 2024
As of 31 Dec 2024,
NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,472,082 shares.
The largest 10 holders included
Decheng Capital LLC, 683 Capital Management, LLC, Greenland Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Boxer Capital Management, LLC, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Laurion Capital Management LP, BlackRock, Inc., and Rock Springs Capital Management LP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.